• Explore /
  • Poster
  • / Salvage chemotherapy with carboplatin plus weekly docetaxel in  patients (pts) with castration- and docetaxel-resistant prostate cancer (DRPC): Associations of patient and disease characteristics with overall survival (OS).

Salvage chemotherapy with carboplatin plus weekly docetaxel in  patients (pts) with castration- and docetaxel-resistant prostate cancer (DRPC): Associations of patient and disease characteristics with overall survival (OS).

Abstract Poster

Authors

null

Christoph W. Reuter

Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Christoph W. Reuter , Michael A. Morgan , Viktor Grünwald , Christoph A. J. von Klot , Axel S. Merseburger , Philipp Ivanyi , Martin Fenner , Arnold Ganser

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 75)

DOI

10.1200/jco.2014.32.4_suppl.75

Abstract #

75

Poster Bd #

E10

Abstract Disclosures

Similar Posters

First Author: Christoph W. Reuter

First Author: Christoph W. Reuter

First Author: Christoph Reuter

First Author: C. W. Reuter